Navigation Links
Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes
Date:9/13/2011

PRINCETON, N.J., Sept. 13, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announced today that screening has begun in a Phase 2b, international study of PSI-7977 and PSI-938, two nucleotide analog polymerase inhibitors for the treatment of chronic hepatitis C (HCV). The QUANTUM trial will evaluate interferon-free regimens of PSI-7977 400mg QD and PSI-938 300mg QD with and without ribavirin over 12 or 24 weeks in patients with HCV who have not been treated previously. The trial will also evaluate the use of PSI-938 monotherapy.

"We are encouraged by the early efficacy and safety data being generated with our nucleotide analogs, PSI-7977 and PSI-938," stated Michelle Berrey, MD, MPH, Pharmasset's Chief Medical Officer.  "The QUANTUM trial is the first interferon-free, all-nucleotide study with an SVR endpoint. The ability to include all HCV genotypes was supported by data from the NUCLEAR study and the interferon free arms of the ELECTRON trial. Data from ELECTRON are expected later this year."

About the Phase 2b QUANTUM Trial This study is designed to enroll approximately 450 patients with chronic HCV of all viral genotypes who have not been treated previously. The primary endpoint of the trial will be sustained virological response (SVR24). Patients will be equally randomized across the following arms:

  • PSI-938 only
  • PSI-938 and PSI-7977
  • PSI-7977 and ribavirin
  • PSI-938, PSI-7977, and ribavirin

  • All arms will be study for both 12 and 24 weeks with a placebo control of 24 weeks.

  • Placebo for 24 weeks

  • HCV patients will be stratified by IL28B status and baseline HCV RNA to ensure balance across cohorts. Cirrhotic and non-cirrhotic patients will be enrolled in the study.

    Additional details on this and all ongoing Pharmasset sponsored trials can be found at

    SOURCE Pharmasset, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Pharmasset Announces Two-for-One Forward Stock Split
    2. Pharmasset to Present at Canaccord Genuity Growth Conference
    3. Pharmasset Reports Fiscal Third Quarter 2011 Financial Results
    4. Pharmasset Announces the Expansion of the ELECTRON Trial in Chronic Hepatitis C
    5. Pharmasset to Present at Two Upcoming Investor Conferences
    6. Pharmasset Reports Fiscal Second Quarter 2011 Financial Results
    7. Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV Genotypes
    8. Pharmasset to Webcast an Investor Event From the EASL Meeting
    9. Pharmasset to Present at Three Upcoming Investor Conferences
    10. Pharmasset to Present at the Leerink Swann Hot Topics Roundtable Conference
    11. Pharmasset Reports Fiscal First Quarter 2011 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/15/2014)... 15, 2014  Mariel Therapeutics, Inc., a clinical stage ... application in Osteoarthritis (OA) and Chronic Kidney Disease (CKD), ... newly formed scientific advisory board. The newly appointed SAB ... to the company as it continues to develop therapies ... to have such leading experts in the area of ...
    (Date:9/15/2014)... Chek Diagnostics, the U.S.-based manufacturer of both ... diagnostic products, has again been named to the ... in America. The Inc. 5000 ranking is ... Diagnostics earned its place on the list by growing ... For Chek Diagnostics, who appears on the ...
    (Date:9/15/2014)... Research and Markets has announced the addition ... Analytics, Delivery Modes & by Whole Slide Image Storage ... to their offering. This report broadly ... and applications. Scanners accounted for the largest share of ... analytics market is expected to grow at the highest ...
    Breaking Medicine Technology:Mariel Therapeutics Appoints World Leading Experts to Inaugural Scientific Advisory Board 2Mariel Therapeutics Appoints World Leading Experts to Inaugural Scientific Advisory Board 3Mariel Therapeutics Appoints World Leading Experts to Inaugural Scientific Advisory Board 4Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 3Global Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Forecasts & Trends to 2018 2Global Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Forecasts & Trends to 2018 3
    ... YORK, April 28, 2011 Reportlinker.com announces ... available in its catalogue: ... System and Drug Regulatory Overview: Cost-containment and ... http://www.reportlinker.com/p0487111/Pharmaceutical-Key-Trends-2011---Healthcare-System-and-Drug-Regulatory-Overview-Cost-containment-and-regulatory-pressures-intensify.html Introduction ...
    ... NEW YORK, April 28, 2011 Reportlinker.com announces that ... catalogue: Pharmaceutical Key Trends 2011 ... http://www.reportlinker.com/p0487118/Pharmaceutical-Key-Trends-2011---Brand-Erosion-Post-Patent-Expiry.html Introduction ... developed pharmaceutical markets, driven by increasing generic competition. However, ...
    Cached Medicine Technology:Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 3Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 4Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 5Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 6Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry 3
    (Date:9/16/2014)... Florida (PRWEB) September 16, 2014 ... of monthly specials this month, kicking off September ... day spa in Clearwater, FL chose to highlight ... for immediate activation upon contact with the skin. ... part of their best-selling lumafirm® anti-aging line. The ...
    (Date:9/16/2014)... The Fertility Centers of New England is proud ... collaboration will give patients access to high-quality frozen donor ... Fertility Centers of New England. , Fairfax Egg Bank ... selection of frozen donor eggs. Access to frozen donor ... The Donor is already screened and her eggs ...
    (Date:9/15/2014)... With the variety of drugs passing ... know the details on each one. However, it is ... falling into their teen’s hands. , Synthetic marijuana ... high school students. With varied, misleading and potentially unreliable ... can be difficult for parents to separate the truth ...
    (Date:9/15/2014)... iFitDress.com, one of the most distinguished dress companies, ... evening dresses to its online store. In addition, the ... products. They are now provided at very low prices, up ... has confidence in the newly unveiled sapphire evening outfits. “I ... from all over the world. Up to now, over 200 ...
    (Date:9/15/2014)... 2014 Aging skin inevitably wrinkles, thins and ... is loss of collagen production. By age 60, skin ... to this slow down. Collagen holds up skin structure. , ... be boosted. There are several ways to do this, but ... cells (non-embryonic). , "The cost is higher than other types ...
    Breaking Medicine News(10 mins):Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 3Health News:FCNE Announces Partnership with Fairfax Egg Bank 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 3Health News:Beautiful Sapphire Evening Dresses Provided By iFitDress.com 2Health News:A Superior Way to Make Skin Younger and Assure Continual Collagen Production, from Sublime Beauty® 2
    ... A Pole who spent 19 years in a coma has woken up ... are no longer in power, a television station announced Friday. ... by a train in 1988, the private channel Polsat said. In an ... ,"She's the one who always took care of me. She ...
    ... man has contracted the deadly bird flu virus, becoming the country's ... Saturday. ,The 19-year-old man tested positive for the H5N1 strain ... Institute of Tropical Medicine in Hanoi, a doctor there told AFP. ... the victim had been admitted on May 19 and was now ...
    ... one source of counterfeit medicines, seized in the European Union ... ,About 31 percent of all fake medicines seized ... percent) and China (8). The three countries are responsible for ... report. ,The seized fake medicines included Viagra, Cialis ...
    ... found evidence that tropical cyclones and hurricanes play an ... transport heat and maintain the climate of North America ... University professor of earth and atmospheric sciences who led ... by MIT professor Kerry Emanuel that suggests there is ...
    ... Inc. announced it has successfully expanded the potential ... ELISA diagnostic research test, FAS-Detect(TM) ELISA for ... ,The current diagnostic technique for this disease is ... use presently, FASgen anticipates the opportunity for use ...
    ... a third child, but the actor is recoiling from making ... not come out in the open to declare that his ... who interviewed the actor, is of the view that if ... forward, awareness about autism would get a major boost. ...
    Cached Medicine News:Health News:India Main Source of Counterfeit Medicines Seized in Europe 2Health News:India Main Source of Counterfeit Medicines Seized in Europe 3Health News:Tropical Cyclones Play Important Role in Climate-control 2Health News:FASgen Announces New Diagnostic Research Test for Steatohepatitis 2Health News:Travolta Maybe Reluctant to Publicaly Discuss About Sons Autism 2
    ... viscosity and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry ... 1000-5000 ... 0.8~1.5 Imprecision(%) ... 10 Dimensions: ...
    ... The Finnpipette Digital offers improved ergonomics ... rounded handle, modified grippy finger rest ... operator comfort and efficiency. Finnpipette Digitals ... power-boosted gearing mechanism (pat. pend.) and ...
    Developed specifically for the 5000/5500 ultrasound consoles....
    Super High Density, multi-frequency, phased array burr hole transducer. Excellent for taking biopsy samples and shunt placements....
    Medicine Products: